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Introduction
In eukaryotic cells, folding and modification of nascent mem-
brane and secreted proteins take place in the ER (Wickner and 
Schekman, 2005). The increased demand of the ER activates 
the unfolded protein response (UPR) (Kaufman, 1999; Mori, 
2000; Patil and Walter, 2001; Harding and Ron, 2002; Ron and 
Walter, 2007). In yeast, the UPR is initiated by activation of the 
ER transmembrane sensor Ire1 (Cox et al., 1993; Mori et al., 
1993), leading to Ire1 autophosphorylation and oligomerization 
(Shamu and Walter, 1996; Lee et al., 2008; Aragón et al., 2009) 
and activation of Ire1 endo-RNase. Ire1 RNase-mediated exci-
sion of the translation-inhibitory intron in HAC1 mRNA is es-
sential for the expression of the Hac1 protein (Cox and Walter, 
1996; Sidrauski and Walter, 1997; Kawahara et al., 1998; 
Rüegsegger et al., 2001). The Hac1 protein, a UPR-specific 
transcription factor, then induces UPR target gene expression, 
including ER resident chaperones and critical protein-folding 
enzymes (Travers et al., 2000).
Although the initial phase of the UPR pathway has been 
well studied, subsequent events leading to the reestablishment 
of ER homeostasis and details of how UPR is finally attenuated 
have only been partially studied. Upon activation, the extent of 
Ire1 RNase activity must be tightly controlled as both ectopic 
expression  of  the  spliced  form  of  HAC1  mRNA  (Kawahara   
et al., 1997) and the overexpression of Ire1 cause cells to grow 
poorly, highlighting the importance of UPR attenuation. Here, 
we establish a UPR attenuation assay in vivo and find an impor-
tant role for the Ire1 kinase domain in attenuating HAC1 splic-
ing beyond its known role in activation.
Results and discussion
To test the molecular steps involved in the recovery phase of the 
UPR, we profiled Ire1 activity by monitoring HAC1 mRNA 
splicing upon UPR activation. Wild-type (WT) yeast cells were 
incubated with the well-characterized UPR inducer tunicamy-
cin (Tm) for an extended length of time. Tm inhibits glycosyl-
ation in the ER, resulting in the accumulation of unglycosylated 
proteins, which leads to the activation of the UPR. Initially, 
spliced HAC1 mRNA appeared upon Tm incubation (Fig. 1, A–I) 
as reported previously (Cox and Walter, 1996; Kawahara et al., 
1998). Under the experimental conditions used, the presence of 
T
he unfolded protein response (UPR) activates Ire1, an 
endoplasmic reticulum (ER) resident transmembrane 
kinase and ribonuclease (RNase), in response to ER 
stress. We used an in vivo assay, in which disappearance 
of the UPR-induced spliced HAC1 messenger ribonucleic 
acid (mRNA) correlates with the recovery of the ER protein-
folding capacity, to investigate the attenuation of the UPR 
in yeast. We find that, once activated, spliced HAC1 mRNA 
is sustained in cells expressing Ire1 carrying phosphomi-
metic mutations within the kinase activation loop, suggesting 
that dephosphorylation of Ire1 is an important step in 
RNase deactivation. Additionally, spliced HAC1 mRNA is 
also sustained after UPR induction in cells expressing Ire1 
with mutations in the conserved DFG kinase motif (D828A) 
or a conserved residue (F842) within the activation loop. 
The importance of proper Ire1 RNase attenuation is dem-
onstrated by the inability of cells expressing Ire1-D828A to 
grow under ER stress. We propose that the activity of the 
Ire1 kinase domain plays a role in attenuating its RNase 
activity when ER function is recovered.
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Figure 1.  Attenuation of spliced HAC1 mRNA levels during the UPR. (A) ire1 yeast strain carrying WT IRE1 (Ire1-WT) was induced for ER stress with 
tunicamycin (Tm) at either middle (I) or early (II) log phases. Activation of IRE1 was monitored by HAC1 mRNA splicing on the Northern blots of isolated 
RNA from cells collected at various time points. Positions of spliced and unspliced HAC1 mRNA are indicated. Differences in HAC1 mRNA splicing are 
highlighted by the dotted blue boxes. (B) An extended UPR time course of Ire1-WT cells in the presence of Tm throughout the time course. The HAC1 mRNA 
membrane was reprobed for KAR2/BiP mRNA. (C) The percentage of HAC1 splicing (dotted line) over total HAC1 mRNA. (D) Ire1-WT cells continuously 
incubated with Tm were not able to splice HAC1 mRNA upon addition of 1 µg/ml of fresh Tm at the 8-h time point. (E) Tm in media that were incubated 
for 8 h was able to splice HAC1 in fresh cells that have never been treated with Tm. (F) The vacuolar carboxypeptidase Y (CPY) activity in Ire1-WT or 
ire1 cells with pRS341 was examined by the ability of CPY to cleave its substrate BTPNA to release p-nitroaniline, which was measured at 410 nm. The 
value of Ire1-WT cells before the UPR was set to 100% CPY activity, and the percentage of CPY activity in Ire1-WT or ire1 cells treated with Tm for the 
indicated lengths of time was calculated. (G) Levels of CPY activity for Ire1-WT cells were also shown (orange) and superimposed on the graph of HAC1 
mRNA splicing from C. Error bars represent standard deviations calculated from at least three independent time courses.43 IRE1 kinase mutant with sustained RNase • Chawla et al.
cells. These results further supported the idea that the dis-
appearance of the spliced HAC1 mRNA reflected the recovery 
of ER protein-folding capacity.
Decrease in spliced HAC1 RNA is sensitive 
to ER luminal information
To further test the relationship between ER functional recovery 
and disappearance of the spliced HAC1 mRNA, we performed   
a UPR recovery assay. If disappearance of the spliced HAC1 
mRNA reflects the ER functional recovery, then removal/washing 
of Tm followed by incubation with fresh media should make   
the kinetics of the spliced HAC1 mRNA disappearance faster.   
To this end, cells were washed and placed in fresh media after a 
2-h Tm treatment (Fig. 2 C), and we monitored the level of 
spliced HAC1 mRNA. At 2 h after Tm washout (and 4 h from 
the beginning of the assay), spliced HAC1 mRNA declined by 
50% (Fig. 2, C [lane 4] and D) and was mostly undetectable 
with the majority of HAC1 mRNA present in the unspliced form 
by 3 h (Fig. 2, B, [open squares], C [lane 5], and D). The faster 
decline of the spliced form of HAC1 mRNA was also observed 
when cells were washed after 1, 1.5, or 0.6 h of Tm treatment, 
at  the  time  before  reaching  the  maximum  levels  of  spliced 
HAC1 mRNA (Fig. 2, E–J), providing further support that the 
decline of spliced HAC1 mRNA represents the recovery phase 
of the UPR (Fig. 2, A and B). The initial 1-h delay before the 
levels of spliced HAC1 mRNA began to decline presumably re-
flects the time required to replenish functional glycosylation 
stores (Fig. 2 F), as N-acetylglucosamine phosphotransferase, 
the primary target of Tm, works at an early step in glycosylation.
Phosphomimetic mutation on the activation 
loop of Ire1 shows no recovery of spliced 
HAC1 mRNA
Because Ire1 undergoes autophosphorylation of the activation 
loop during UPR induction (Shamu and Walter, 1996, Lee et al., 
2008), we reasoned that its dephosphorylation might constitute 
at least one of the Ire1 deactivation events. We, therefore, pre-
dicted that a phosphomimetic Ire1 mutant in which three of the 
previously  described  phosphorylation  sites  on  the  activation 
loop (Shamu and Walter, 1996) were mutated to aspartate (Ire1-
S840D/S841D/T844D) should be constitutively active or should 
not be able to recover once activated. Cells expressing Ire1-
S840D/S841D/T844D  were  not  constitutively  active  for  the 
splicing of HAC1 mRNA, but upon Tm addition, these cells 
spliced HAC1 mRNA efficiently (Fig. 2, K and L). Thus, phos-
phorylation at these three residues alone is not sufficient to acti-
vate Ire1, but either phosphorylation of the fourth residue on the 
recently identified activation loop (Lee et al., 2008) or addi-
tional events beyond phosphorylation, such as sensing of the 
ER environment via the Ire1 sensor domain, must be required 
for activation of Ire1 (Okamura et al., 2000; Credle et al., 2005; 
Zhou et al., 2006; Kimata et al., 2007; Oikawa et al., 2007). 
Importantly, in marked contrast to WT cells, Ire1-S840D/
S841D/T844D cells continued to display the spliced form of HAC1 
mRNA at later times or even after removal of Tm (Fig. 2, M–P), 
suggesting that dephosphorylation is required for attenuating 
Ire1. Collectively, the disappearance of the spliced HAC1 mRNA 
spliced HAC1 mRNA was sustained for ≤6 h, suggesting that 
Ire1 RNase remained activated (Fig. 1, A–I). We reasoned that 
metabolic states of cells might affect either the activation or re-
covery kinetics of the UPR. Thus, we performed another UPR 
time course in which Tm was added to the same WT yeast cell 
except when they were at their earlier point of log phase.   
Although kinetic activation of Tm-induced HAC1 mRNA splic-
ing was similar to that shown in Fig. 1 (A–I), we found that 
most of the spliced HAC1 mRNA disappeared after 6 h and the 
majority of HAC1 mRNA was of the unspliced form (Fig. 1,   
A–I). A possible explanation for the disappearance of the spliced 
HAC1 mRNA after 6 h may be the restoration of the ER protein-
folding capacity and, thus, the termination of the UPR by inac-
tivating Ire1 RNase. In a further extended time course (Fig. 1 B), 
the kinetics of appearance and the following disappearance of 
spliced HAC1 mRNA correlated well with the level of KAR2 
mRNA, an immediate Hac1 transcription factor target, suggest-
ing the potential recovery of ER protein-folding homeostasis at 
the later stages.
However,  another  explanation  for  decreased  levels  of 
spliced HAC1 mRNA could be the loss of Tm activity over time. 
We added a second dose of fresh Tm (1 µg/ml) to the yeast cul-
ture that had already been incubated with Tm for 8 h (Fig. 1 D, 
lane 4, fresh Tm). Cells were no longer responsive to Tm the sec-
ond time (Fig. 1 D, lanes 5 and 6), whereas the initial exposure to 
Tm effectively induced Ire1 (Fig. 1 D, lanes 2 and 3). Further-
more, Tm in the yeast media was still capable of activating the 
UPR. When Tm-containing media were taken from those grown 
for 8 h and added into fresh cells, HAC1 mRNA splicing oc-
curred efficiently (Fig. 1 E, lanes 5 and 6). In addition to the po-
tency of Tm, these results also revealed that no “toxic” agent 
preventing HAC1 mRNA splicing was secreted in the media dur-
ing the initial incubation of cells with Tm. Collectively, these re-
sults suggest that decreased levels of spliced HAC1 mRNA at 
later times were unlikely to be caused by a loss of the ability of 
Tm to induce the UPR.
Finally, we measured ER protein-folding capacity at a 
later time by examining the recovery of the carboxypeptidase Y 
(CPY) function. CPY is a vacuolar peptidase that traverses the 
ER, where it undergoes multiple modifications, including gly-
cosylation, to become an enzymatically active mature form. If 
the later disappearance of spliced HAC1 mRNA reflects the re-
covery of the ER function, glycosylation and overall folding of 
proteins should be restored. Thus, we monitored the CPY enzy-
matic activity during a Tm time course to test whether the ER 
protein-folding state was later recovered. CPY activity present in 
WT and ire1 cells that were measured by a cleavage assay using 
the colorimetric substrate N-benzoyl-l-tyrosine p-nitroanilide 
(BTPNA) in vitro (Fig. 1 F; Stevens et al., 1986; Ohi et al., 
1996; Lahav et al., 2004) was decreased upon UPR induction 
as anticipated.
Subsequently, at 7 h, Ire1-WT cells were able to regain 
CPY activity at levels similar to what was present before UPR 
activation (Fig. 1, F and G). The recovery in CPY activity was 
in inverse correlation with the level of the spliced form of HAC1 
mRNA and occurred in a WT Ire1-dependent manner because 
CPY activity remained at low levels in ire1 UPR-deficient JCB • VOLUME 193 • NUMBER 1 • 2011   44
Figure 2.  Removal of Tm from the medium makes the recovery of spliced HAC1 mRNA faster in Ire1-WT cells but not in Ire1-S840D/S841D/T844D cells. 
(A) Ire1-WT cells incubated with Tm for the amount of time indicated. (B) Quantitation of HAC1 mRNA splicing (closed square). (C) After a 2-h incubation 
with Tm, Ire1-WT cells were recovered from ER stress by washing them in warm fresh media (Wash) and incubated further without Tm for the remaining time. 45 IRE1 kinase mutant with sustained RNase • Chawla et al.
suggest that the Ire1 kinase domain plays an important role in 
terminating the UPR in addition to the activation of HAC1 
mRNA splicing.
Because phosphorylation of the activation loop is known 
to induce conformational changes, including movement of 
the loop itself, the DFG aspartate may play a role in estab-
lishing  the  position  of  the  activation  loop,  depending  on   
the state of ATP binding and/or autophosphorylation. Thus, 
D828A may allow the Ire1 RNase domain to mimic an active 
conformation for splicing HAC1 mRNA, which is normally 
achieved by autophosphorylation of the activation loop. If 
this were the case, it might rescue the minimal HAC1 mRNA-
splicing levels of the Ire1-S840A/S841A/T844A activation 
loop mutant. Indeed, HAC1 mRNA splicing in Ire1-D828A/
S840A/S841A/T844A cells increased significantly to levels 
similar to that of Ire1-D828A at 2 h after UPR induction 
(Fig. 4 A), suggesting that the D828A mutation could convert 
the nonphosphorylated activation loop into a conformation 
suitable for RNase activation.
Finally, beyond the important phosphorylation sites on the 
activation loop, we reasoned that additional residues might exist 
to participate in such conformational changes. We inspected the 
presence of a conserved phenylalanine residue at position 842 
(Fig. 4 B) and examined the effect of mutating F842 to alanine 
on HAC1 splicing. We found that Ire1-F842A was activated to 
WT levels but also that, like Ire1-D828A, it showed sustained 
HAC1 mRNA splicing over an extended time course (Fig. 4 C). 
The effect of the mutation was specific to phenylalanine at 842 
as the mutation of arginine at position 843 on the activation loop 
to alanine had no effect on Ire1 RNase activity, demonstrating 
that not all Ire1 mutants with significant RNase activity result in 
the phenotype found in Ire1-D828A. Collectively, these results 
suggest that the activation loop of Ire1 is important not only 
during activation of Ire1 but also during the attenuation of HAC1 
mRNA splicing. In addition to simple dephosphorylation, Ire1-
D828A and -F842A phenotypes have revealed the presence of 
another critical event for the Ire1 attenuation process.
Proper attenuation of HAC1 splicing during UPR signal-
ing must be important for cell physiology, although very little 
has been described so far. To determine the functional conse-
quences of the sustained UPR, we examined the ability of either 
WT or D828A cells to grow under the UPR-induced conditions. 
Both WT and D828A cells grew similarly in the absence of Tm 
(Fig. 4 D). However, D828A cells were reduced 25-fold in 
their ability to survive when grown for an extended amount of 
time on plates with growth medium containing 0.4 µg/ml Tm. 
Thus, the inability of D828A cells to attenuate HAC1 splicing in 
a timely manner diminished the ability of the cells to survive the 
extended activation of UPR.
at the later stage of the UPR time course reflects the reestablish-
ment of ER protein-folding homeostasis, providing an experi-
mental system to study the recovery phase of the UPR.
D828A Ire1 mutation causes the 
sustained presence of spliced HAC1 mRNA
Using the UPR recovery assay, we examined whether any 
cytoplasmic domain mutants, specifically kinase domain mu-
tants, would be defective in the transmission of the UPR   
attenuation signals from the ER luminal domain and display 
defects in decline of spliced HAC1 mRNA upon removal of 
Tm. Most kinase domains, including Ire1, have critical resi-
dues that are important for ATP binding and phosphorylation. 
Specifically, the aspartate at 828 (D828) is within the con-
served DFG kinase motif and is predicted to be involved in 
the coordination of  and  phosphates of ATP with Mg
2+  
(De Bondt et al., 1993; Johnson et al., 1996; Huse and Kuriyan, 
2002; Lee et al., 2008) in the kinase pocket. In an in vitro   
kinase assay, we found that Ire1-D828A was unable to un-
dergo autophosphorylation despite its ability to bind to ATP, 
confirming that it is an inactive kinase (Fig. S1, C and D). 
Mutating to the alanine of this residue (Ire1-D828A) resulted 
in the sustained presence of spliced HAC1 mRNA upon ER 
stress induction for ≤8 h. Only after that was there a gradual, 
small decline (Fig. 3, A and B). In parallel, the transcript of 
KAR2 was also sustained at later times. The observed differ-
ences in spliced HAC1 and KAR2 mRNA were unlikely to be 
caused by the expression levels of Ire1-WT or Ire1-D828A 
proteins, as they were detected at similar levels (Fig. S1 A), 
and an increase in Ire1-D828A expression by a 2µ plasmid 
did not change the profile of sustained HAC1 mRNA splicing 
(Fig. S1 B). Furthermore, sustained HAC1 mRNA splicing 
was also observed with Ire1-D828N (unpublished data). In the 
recovery assay, although washing/removal of Tm and the sub-
sequent growth in fresh media facilitated the disappearance of 
spliced  HAC1  mRNA  in  Ire1-WT  cells,  Ire1-D828A  cells 
showed essentially no recovery where a spliced form of HAC1 
mRNA was persistently present, even after Tm removal. The 
presence of spliced HAC1 mRNA was sustained regardless of 
the length of Tm treatment before removal of Tm (Fig. 3, C–J), 
which is similar to cells with the phosphomimetic Ire1 mutant 
(S840D/S841D/T844D). We also tested the involvement of 
the other conserved kinase domain residues, lysine at 702 
(K702) and aspartate at 797 (D797), that are predicted to be 
important for ATP binding and phosphotransfer, respectively 
(De Bondt et al., 1993; Johnson et al., 1996; Huse and Kuriyan, 
2002; Lee et al., 2008). However, neither of these mutants   
activated Ire1 RNase, making it impossible to analyze the dis-
appearance of HAC1 mRNA (Fig. S2). Thus, these results 
The white line between lanes 2 and 3 indicates the removal of intervening lanes. (D) Quantitation of HAC1 mRNA splicing for panel C is shown. Blue 
numbers represent the amount of time after washing. (E–J) Cells were recovered after 1.5 (E and F)-, 1 (G and H)-, and 0.6 (I and J)-h Tm incubation, and 
the splicing of HAC1 mRNA was quantified. In I, intervening lanes were spliced out between lanes 2 and 3, lanes 3 and 4, and lanes 4 and 5. (K) Ire1-S840D/
S841D/T844D cells continue to retain spliced HAC1 mRNA once activated without recovery. (L) The percentage of spliced HAC1 mRNA (closed circle). 
(M–P) Ire1-S840D/S841D/T844D cells were recovered from Tm after 2 (M and N)- or 6-h (O and P) incubation, and the percentage of HAC1 mRNA 
splicing was quantified. In M, the splicing of two different parts of a northern membrane is indicated by the white line between lanes 1 and 2. Error bars 
indicate standard deviations from at least three independent experiments.
 JCB • VOLUME 193 • NUMBER 1 • 2011   46
Figure 3.  Spliced HAC1 mRNA is sustained in Ire1-D828A cells upon ER stress. (A) Ire1-D828A cells were treated continuously with Tm for the indicated 
length of time for HAC1 mRNA splicing on Northern gels and reprobed for the level of KAR2 mRNA. As a comparison, the Tm time course of Ire1-WT cells 
(Fig 1B) was shown. (B) The percentage of HAC1 mRNA spliced for Ire1-WT (closed square) and Ire1-D828A (closed circle). (C–J) Sustained presence of 
spliced HAC1 RNA in Ire1-D828A cells even after the removal of Tm and resuspension in fresh media without Tm. (D) The percentage of HAC1 mRNA 
splicing in cells treated with continuous Tm (closed circle) and in cells recovered after 2-h Tm treatment (open circle). (F, H, and J) Close up of the quantita-
tion for the first 5 h of recovery. Error bars are standard deviations from at least three repeats.47 IRE1 kinase mutant with sustained RNase • Chawla et al.
phenotype of cells becoming insensitive to the reestablishment 
of the ER functional capacity and having the sustained presence 
of the spliced HAC1 mRNA. This was in contrast to WT cells   
in which removal of Tm, an ER stress agent, facilitated the dis-
appearance of the spliced HAC1 mRNA. The importance of the 
timely attenuation of the UPR was supported by the inability of 
Ire1-D828A cells to sustain their growth, even though these cells 
are able to mount HAC1 mRNA splicing at the initial phase.
One interesting finding is that mutations in multiple dif-
ferent residues of the Ire1 kinase domain showed similar pheno-
types of the sustained presence of the spliced HAC1 mRNA. 
Simultaneously, in addition to the mutants we report here, a 
new study independently shows that another kinase-inactive 
Although the importance of Ire1 kinase domain functions 
in the activation of the UPR has been demonstrated previously 
(Tirasophon et al., 2000; Papa et al., 2003; Lee et al., 2008), we 
report here that Ire1 kinase function plays an important role in 
the attenuation of the activated Ire1 RNase. In addition to the 
initial responses for the increased demands for ER functions, 
Ire1 must also remain sensitive to the information that ER func-
tional capacity is reestablished to attenuate the activating signal 
in a timely manner. The Ire1 kinase domain plays a role in trans-
mitting the ER luminal information to Ire1 RNase during the at-
tenuating phase of the UPR. We have found that mutating 
several residues within the Ire1 kinase domain, D828, F842, 
S8440, S841, and T844, resulted in an essentially similar 
Figure 4.  An additional kinase domain mutation displays a sustained HAC1 mRNA-splicing phenotype, and the inability to attenuate HAC1 splicing in 
Ire1-D828A is more sensitive to ER stress. (A) The D828A mutation partially rescues RNase-inactive Ire1-S840A/S841A/T844A. For each mutant, 0- and 
2-h time points are shown. (B) Alignment of amino acid residues in the activation loop surrounding the DFG motif (shown in red). Serines at 840 and 841 
and threonine at 844 (shown in blue) become phosphorylated upon UPR activation (Shamu and Walter, 1996; Lee et al., 2008). The conserved phenyl-
alanine (F843) is shown in the purple box. (C) A mutation at the conserved phenylalanine in the activation loop (Ire1-F842A) phenocopies the Ire1-D828A 
mutant. (D) Ire1-D828A cells are more sensitive to ER stress. Ire1-WT or Ire1-D828A cells were grown to an OD600nm of 0.25, and then cells were serially 
diluted by fivefold and spotted on plates containing different amounts of Tm (0, 0.1, and 0.4 µg/ml). Error bars represent standard deviations from three 
independent experiments. Dros., Drosophila melanogaster.JCB • VOLUME 193 • NUMBER 1 • 2011   48
mammalian  cells  appears  to  be  negatively  regulated  by  the 
XBP1 protein coded from the unspliced form of XBP1 mRNA 
(pXBP1(U); Yoshida et al., 2006). As pXBP1(U) concentration 
increases at later times, heterodimer formation with a spliced 
form (pXBP1(S)) causes pXBP1(S) to be transported to the 
cytoplasm where it undergoes proteasome-mediated degra-
dation. Such a mechanism may allow the cell to inactivate the 
transcriptional response even before the inactivation of Ire1. 
In yeast, although no evidence for the production of pHAC1(U), 
presumably caused by the presence of the translational in-
hibitory intron within unspliced HAC1, is found, other nega-
tive factors generated during the UPR may facilitate UPR 
down-regulation.
Human diseases that correlate with insufficient UPR acti-
vation are rapidly increasing. For example, the loss of pancre-
atic  cells in juvenile diabetic patients (Wolcott–Rallison 
syndrome) is thought to be caused by the loss of the functional 
PERK protein, another ER transmembrane kinase involved in 
UPR induction (Harding et al., 2001). Our finding that Ire1 can 
be trapped in an activated state for an extended length of time 
by modulation of the kinase domain may provide a basis for the 
development of novel strategies for augmenting UPR insuffi-
ciency in some human diseases.
Materials and methods
Yeast strains and plasmids
Yeast strains carrying various forms of IRE1 were generated by the standard 
yeast transformation protocol (Elble, 1992). Mutant forms of IRE1 were 
generated using the QuickChange kit (Agilent Technologies) and confirmed 
by sequencing the entire coding region. Tables I and II summarize the yeast 
strains and plasmids used in this study. The KAR2 plasmid was a gift from 
D. Ng (National University of Singapore, Singapore).
Cell culture and growth conditions
All yeast strains were grown in synthetic complete media supplemented 
with inositol at a final concentration of 50 µg/ml. Tm (EMD) was added to 
mutant Ire1 (D797N or K799N) is unable to attenuate Ire1 
RNase (see Rubio et al. in this issue). As these residues are 
also projected toward the kinase catalytic cleft, they may pro-
vide the framework for conformational changes needed for at-
tenuating Ire1 RNase activity. For example, the involvement   
of the DFG motif in a more direct catalytic function beyond   
nucleotide binding (Johnson et al., 1996; Huse and Kuriyan, 
2002) has been predicted from structural studies with insulin 
receptor kinase (IRK) and Src and Abl kinases (Till et al., 
2001; Levinson et al., 2006). The ability of the DFG motif to 
affect activation loop conformation is also supported by the 
finding that the D828A mutation converts the nonphosphory-
latable  activation  loop  mutant  (Ire1-S840A/S841A/T844A) 
into an active RNase (Fig. 4 A).
Conversely, in IRK (Till et al., 2001), alteration of the 
IRK activation loop residue (IRK-D1161A) induced a structural 
disorder in the IRK nucleotide-binding pocket, mimicking a 
transition state. Similarly, the conserved activation loop phenyl-
alanine (F842) on the Ire1 activation loop may be involved in 
the establishment of certain critical hydrophobic interactions 
that allow a unique conformational link with the nucleotide-
binding pocket. Thus, a specific conformational link between 
the residues within the nucleotide binding and the activation 
loop, including the DFG motif and phosphorylation sites, may 
provide the molecular bases for using the evolutionarily con-
served kinase domain for both activation and attenuating signals 
in response to changes in the luminal domain of Ire1.
Several signaling pathways use multiple strategies for   
signal attenuation (Dikic and Giordano, 2003). In mammalian 
cells, a recent study has shown that the spliced form of XBP1 
mRNA goes away after 12 h of a Tm incubation time course 
(Lin et al., 2007). In contrast, other UPR inducers, such as 
PERK or ATF6, remain active for a while, suggesting that Ire1 
was inactivated even before the ER capacity recovery. In addi-
tion to the splicing of XBP1 mRNA, however, the UPR in 
Table I.  Yeast strains used in this study
Strain Genotype Source/reference
MNY1000 MAT; ura3-1; leu2-3-112; his3-11-15; trp1-1; ade2-1; can1-100 Cox et al., 1993
MNY1013 Same as MNY1000 except ire1::URA3 Cox et al., 1993
MNY1014 Same as MNY1013 with pRS314 This study
MNY1015 Same as MNY1013 with pCS110 This study
MNY1016 Same as MNY1013 with pMHR001 This study
MNY1017 Same as MNY1013 with pMHR002 This study
MNY1018 Same as MNY1013 with pMHR003 This study
MNY1019 Same as MNY1017 with pMR713 This study
MNY1020 Same as MNY1017 with pRS315 This study
MNY1021 Same as MNY1015 with pRS315 This study
MNY1022 Same as MNY1013 with pCS122 This study
MNY1023 Same as MNY1013 with pMHR004 This study
MNY1024 Same as MNY1015 with pMR713 This study
MNY1025 Same as MNY1013 with pMHR005 This study
MNY1026 Same as MNY1013 with pMHR006 This study
MNY1027 Same as MNY1013 with pMHR007 This study
MNY1028 Same as MNY1013 with pMHR008 This study
MNY1029 Same as MNY1013 with pMHR010 This study
MNY1030 Same as MNY1013 with pMHR011 This study49 IRE1 kinase mutant with sustained RNase • Chawla et al.
by staining the gel with SYPRO ruby staining based on the manufactur-
er’s instructions (Invitrogen).
Yeast protein extract and Western blot analyses
Pellets from cells with an OD600 of 3 were resuspended in 100 µl SUME 
(1% SDS, 8 M urea, 10 mM MOPS, pH 6.8, and 10 mM EDTA) with 
protease inhibitors (1 mM PMSF, 10 µg/ml tosyl phenylalanyl chloro-
methyl ketone, leupeptin, and pepstatin). The total cell extract was pre-
pared by vortexing in the presence of 100 µl of 0.5-mm acid-washed 
glass beads at 4°C. 100 µl of 2× USB (75 mM MOPS, pH 6.8, 4% 
SDS, 200 mM DTT, and 8 M urea) was then added, and the samples 
were incubated at 65°C for 10 min. Proteins were isolated on SDS-
PAGE and were transferred on to a nitrocellulose membrane, which was 
probed for either Ire1-WT or Ire1-D828A using an anti-HA antibody 
(Santa Cruz Biotechnology, Inc.).
Fluorescent nucleotide-binding assay
An  increasing  amount  (5–120  µM)  of  the  fluorescent  nucleotides   
N-methylanthraniloyl  nucleotide  (MANT)-ADP  and  MANT-ATP  (Invitrogen) 
were mixed with 1.4 µM recombinant Ire1(LKT) in 25 mM Tris, pH 7.5, 0.4 M 
NaCl, 5% glycerol, and 10 mM MgCl2 before being excited at 280 nm. 
The emission was measured at 440 nm using a spectrofluorometer (Fluoro-
max; Horiba Scientific) as described previously in detail (Ni et al., 2000). 
The equilibrium dissociation constants were determined by plotting the 
changes in fluorescence at 440 nm as a function of nucleotide concentra-
tion (either MANT-ATP or MANT-ADP, 5–120 µM) and are the concentra-
tions of a MANT nucleotide at which 50% of the maximum fluorescence 
changes was measured as described previously (Adams and Taylor, 1992; 
Ni et al., 2000).
Online supplemental material
Fig. S1 shows that Ire1-D828A is expressed and binds ATP at a level 
similar to Ire1-WT but is an inactive kinase. Fig. S2 shows that nucleo-
tide binding and phosphorylation are important for the full activation of 
Ire1 RNase. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201008071/DC1.
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a final concentration of 1 µg/ml to induce the UPR when required. Yeast 
strains were grown overnight to saturation with an OD600 of 1.5. The fol-
lowing morning, cells were diluted to 0.75–0.8 × 10
7 cells/ml and allowed 
to recover for one doubling time in fresh media to reach an OD600 of 0.5. 
Upon addition of Tm, cells were collected for analysis of RNA at the time 
points indicated in the figures.
Isolation of RNA and Northern blot analyses
Total RNA was isolated according to the hot phenol method (Köhrer 
and Domdey, 1991). RNA was separated by electrophoresis on 1.5% 
agarose  gels  containing  6.7%  formaldehyde  and  transferred  to  a   
Duralon-UV membrane (Agilent Technologies) as previously described 
(Cox and Walter, 1996). Hybridization was performed at 65°C over-
night in church buffer containing 0.5 M Na2HPO4, 1 mM EDTA, and 
7% SDS, pH 7.5. Quantitation of Northern blots was performed on an 
imager system (Typhoon 9400; GE Healthcare). All probes were la-
beled with -[
32P]deoxy-CTP using a DNA-labeling system (Megaprime; 
GE  Healthcare).  The  probe  used  for  detecting  both  spliced  and  un-
spliced forms of HAC1 mRNA was as described previously (Papa et al., 
2003). The KAR2 probe was generated by PCR of a 0.5-kb fragment of 
the coding region. The percentage of HAC1 splicing was calculated as 
the percentage of spliced over total HAC1 mRNA.
CPY functional assay
CPY catalyzed the hydrolysis of its substrate BTPNA (Sigma-Aldrich) to give 
the yellow product p-nitroaniline, whose production was followed by an in-
crease in absorbance at 410 nm. Cells were permeabilized in a buffer con-
taining 100 mM Tris, pH 7.6, and 0.2% Triton X-100 for 30 min at 37°C 
in the presence of BTPNA. Upon permeabilization, the BTPNA gained ac-
cess to mature vacuolar CPY for the cleavage reaction, which was mea-
sured by absorbance value in 410 nm. The absorbance value obtained 
from UPR-uninduced cells was set to 100%, and the percentage of func-
tional CPY activity was calculated.
Recombinant Ire1 protein expression and in vitro kinase assay
The GST-tagged WT Ire1-(linker kinase tail [LKT])p containing the entire 
cytosolic domain of Ire1 (aa 556–1,115) was expressed and purified 
as described previously (Sidrauski and Walter, 1997). The fusion pro-
tein was purified using glutathione–Sepharose beads (GE Healthcare). 
All the mutant forms of Ire1 were prepared essentially in a similar man-
ner. In vitro autophosphorylation of various forms of the recombinant 
Ire1p was performed as described previously (Nock et al., 2001). In brief, 
the recombinant Ire1 was incubated in kinase buffer (10 mM Hepes,   
pH 7.5, 5 mM Mg(OAc)2, 25 mM KOAc, and 1 mM DTT) containing 
200 µM of unlabeled ATP and 167 µCi -[
32P]ATP (7,000 Ci/mmol; 
ICN) at 30°C for 30 min before being analyzed on 7% SDS-PAGE. Lev-
els of various forms of the recombinant Ire1 proteins were examined 
Table II.  Plasmids used in this study
Plasmid Description Backbone Source/reference
pCS110 WT IRE1 gene (Trp) pRS314 (cen/ars) Cox et al., 1993
pCS122 WT IRE1 gene (Trp) yEPLac112 (2µ) Shamu and Walter, 1996
pMR713 WT KAR2 gene (Leu) pRS315 (cen/ars) Ng et al, 2000
pMHR001 K702A mutation in IRE1 pCS110 This study
pMHR002 D828A mutation in IRE1 pCS110 This study
pMHR003 S840A/S841A/T844A mutations in IRE1 pCS110 This study
pMHR004 D828A mutation in IRE1 pCS122 This study
pMHR005 S840D/S841D/T844D mutations in IRE1 pCS110 This study
pCF210 Escherichia coli expression plasmid for GST-IRE1 (aa 556–1,115) pGEX-6P-2 Sidrauski and Walter, 1997
pMHR006 D797A mutation in Ire1 pCS110 This study
pMHR007 R843A mutation in Ire1 pCS110 This study
pMHR008 F842A mutation in Ire1 pCS110 This study
pMHR009 E. coli expression plasmid for His-IRE1 (aa 642–1,115) pET15b This study
pMHR010 D828A/S840A/S841A/T844A mutations in IRE1 pCS110 This study
pMHR011 D828N mutation in IRE1 pCS110 This study
pMHR012 E. coli expression plasmid for His-IRE1 (aa 642–1,111) with D828A pMHR009 This study
cen/ars, centromeric/autonomously replicating sequence.JCB • VOLUME 193 • NUMBER 1 • 2011   50
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